| scholarly article | Q13442814 |
| P50 | author | Thomas Wisniewski | Q41043812 |
| P2093 | author name string | Barry Reisberg | |
| Izabela Kuchna | |||
| Jarek Wegiel | |||
| Jerzy Wegiel | |||
| Krzysztof Nowicki | |||
| Michael Flory | |||
| Shuang Yong Ma | |||
| Mony de Leon | |||
| Wayne P Silverman | |||
| Eulalia Badmaev | |||
| P2860 | cites work | No disease in the brain of a 115-year-old woman | Q81410464 |
| The pathological process underlying Alzheimer's disease in individuals under thirty | Q82953907 | ||
| Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease | Q48820847 | ||
| Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field | Q48938153 | ||
| Unbiased stereological estimation of the number of neurons in the human hippocampus | Q48956996 | ||
| Lewy body-related alpha-synucleinopathy in the aged human brain | Q50282783 | ||
| Dysmetria of thought: clinical consequences of cerebellar dysfunction on cognition and affect | Q50301691 | ||
| The amygdala and emotional memory. | Q51121525 | ||
| No loss of hippocampal neurons in AIDS patients. | Q52027116 | ||
| Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. | Q52036170 | ||
| Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. | Q53186541 | ||
| Clinical validity of Braak neuropathological staging in the oldest-old | Q53234837 | ||
| Hippocampal neurons in pre-clinical Alzheimer's disease. | Q53263608 | ||
| Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. | Q53274954 | ||
| Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. | Q53312524 | ||
| Successful Aging | Q55895195 | ||
| Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease | Q57132920 | ||
| Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis | Q64865584 | ||
| Parkinson's disease | Q67656912 | ||
| Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease | Q67960261 | ||
| Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians | Q70700570 | ||
| Amygdaloid changes in aging and dementia | Q71350323 | ||
| The human entorhinal cortex: a cytoarchitectonic analysis | Q71700880 | ||
| Prevalence of dementia in centenarians | Q73540021 | ||
| Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Q73789480 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation | Q28208309 | ||
| Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease | Q28242505 | ||
| Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | Q28910345 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology | Q29617284 | ||
| Brain-region-specific alterations of the trajectories of neuronal volume growth throughout the lifespan in autism | Q30577423 | ||
| Cognitive reserve | Q33452282 | ||
| Brain aging in the oldest-old | Q34034151 | ||
| Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum | Q34254256 | ||
| Aging of the human cerebellum: a stereological study | Q34269538 | ||
| Cognitive and language functions of the human cerebellum | Q34291039 | ||
| Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala | Q34327607 | ||
| Cognitive reserve and the neurobiology of cognitive aging | Q34367363 | ||
| Regional brain changes in aging healthy adults: general trends, individual differences and modifiers | Q34392779 | ||
| Primary age-related tauopathy (PART): a common pathology associated with human aging | Q34445021 | ||
| Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process? | Q34445601 | ||
| PART is part of Alzheimer disease | Q34460027 | ||
| PART, a distinct tauopathy, different from classical sporadic Alzheimer disease | Q34467464 | ||
| Aging: overview. | Q34497428 | ||
| Dementia in the oldest old. | Q34522497 | ||
| Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry | Q34556945 | ||
| The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease | Q34992780 | ||
| "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? | Q35208143 | ||
| Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies | Q35231770 | ||
| Preclinical AD Workgroup staging: pathological correlates and potential challenges. | Q35633470 | ||
| Exploring the neural basis of cognitive reserve in aging | Q35690969 | ||
| Dementia from Alzheimer disease and mixed pathologies in the oldest old. | Q36012190 | ||
| Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment | Q36393028 | ||
| Brain pathologies in extreme old age. | Q36395714 | ||
| Youthful memory capacity in old brains: anatomic and genetic clues from the Northwestern SuperAging Project | Q36522811 | ||
| Superior memory and higher cortical volumes in unusually successful cognitive aging | Q36541313 | ||
| Altered Proteins in the Aging Brain | Q36692073 | ||
| Morphometry of the human substantia nigra in ageing and Parkinson's disease | Q36727465 | ||
| Selective vulnerability in brain hypoxia | Q36923288 | ||
| TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies | Q36951533 | ||
| Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship | Q37218110 | ||
| Lewy body pathology in normal elderly subjects | Q37246606 | ||
| Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease | Q37332710 | ||
| Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease | Q37914845 | ||
| Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia | Q37998203 | ||
| Cognitive reserve in ageing and Alzheimer's disease. | Q38053269 | ||
| Longevity and its regulation: centenarians and beyond | Q38214937 | ||
| Challenges of multimorbidity of the aging brain: a critical update | Q38236878 | ||
| Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
| Aging and Extrapyramidal Function | Q39129889 | ||
| Stereological analysis of amygdala neuron number in autism. | Q40305697 | ||
| Identification of normal and pathological aging in prospectively studied nondemented elderly humans | Q41082915 | ||
| The neuropathological changes associated with normal brain aging | Q41225416 | ||
| Neurobiology of fear responses: the role of the amygdala | Q41580973 | ||
| Striatal dopamine deficiency in Parkinson's disease: role of aging | Q41993839 | ||
| Amygdalar volume and emotional memory in Alzheimer's disease | Q42052621 | ||
| Frequency of stages of Alzheimer-related lesions in different age categories | Q42445469 | ||
| Amygdala pathology in Parkinson's disease | Q42489917 | ||
| Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease | Q42692714 | ||
| APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. | Q44761865 | ||
| Neuropathological background of twenty-seven centenarian brains | Q44991568 | ||
| The incidence of dementia: a meta-analysis | Q45174488 | ||
| Amyloid deposition is decreasing in aging brains: an autopsy study of 1,599 older people. | Q46025094 | ||
| Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease | Q47918430 | ||
| Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function | Q47945508 | ||
| Neuropathology of cognitively normal elderly | Q48125911 | ||
| Differential aging of the human striatum: longitudinal evidence | Q48171028 | ||
| Neuron loss and shrinkage in the amygdala in Alzheimer's disease | Q48203989 | ||
| Regionally specific loss of neurons in the aging human hippocampus | Q48255198 | ||
| Neurons may live for decades with neurofibrillary tangles | Q48277531 | ||
| Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease | Q48442778 | ||
| Conscious and unconscious emotional learning in the human amygdala | Q48451653 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome. | Q48655623 | ||
| Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes | Q48679838 | ||
| Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease | Q48762615 | ||
| Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease | Q48790608 | ||
| Effects of age on tissues and regions of the cerebrum and cerebellum. | Q48818942 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 439-457 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or β-Amyloidosis | |
| P478 | volume | 76 |
| Q61449631 | A Key Role for Subiculum-Fornix Connectivity in Recollection in Older Age |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q55365163 | Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. |
Search more.